Evaluating Diagnostic Strategies Involving Multiple Tests

Published May 17, 2013
Leicester, UK – It is essential that the relationships between diagnostic tests are understood in order to ensure the most effective diagnoses of diseases, as they rarely perform independently. To date, both clinical and economic evaluations of combinations of diagnostic tests have mostly assumed the tests to perform independently of one another. However, doing so will often over-estimate the performance of sequences of diagnostic tests. Researchers from the University of Leicester attempted to show how failure to allow for correlations between test performance may led to erroneous conclusions. By creating a framework for the evaluation of the diagnostic performance of sequences of tests and applying the framework to an economic evaluation of diagnostic strategies for Deep Vein Thrombosis, they determined that allowing for correlations between tests had considerable impact on the evaluation results. Professor Alex Sutton, researcher on the studies says, "As well as presenting a novel method in an under-researched area, this work also has important implications for those designing diagnostic evaluation studies in the future since it highlights the need for studies which evaluate multiple tests." The full studies: “Evaluating the Cost-Effectiveness of Diagnostic Tests in Combination: Is It Important to Allow for Performance Dependency?” and “Meta-Analysis of the Accuracy of Two Diagnostic Tests Used in Combination: Application to the Ddimer Test and the Wells Score for the Diagnosis of Deep Vein Thrombosis” are published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×